• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Cretex Companies CEO Steps Down

    Data Show Porex's Medical Device Filtration Materials Protect Against Virus, Bacteria Spread

    Endoscopic Hemostasis Devices Market Valued at $730 Million

    Henry Schein Buys Majority Interest in Prism Medical Products

    Boston Scientific's Vercise Genus DBS Earns FDA Approval
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Creganna Medical, part of TE Connectivity

    Spectrum Plastics Group

    Unicep

    Element

    maxon
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Medbio LLC

    Spectrum Plastics Group

    Concise Engineering

    Creganna Medical, part of TE Connectivity

    FUTEK Advanced Sensor Technology Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    FDA-Cleared Artificial Intelligence Breast Cancer Diagnosis System Launched by Paragon Biosciences

    Product will help provide a more accurate diagnosis for breast cancer patients, stemming from three decades of research at the University of Chicago.

    FDA-Cleared Artificial Intelligence Breast Cancer Diagnosis System Launched by Paragon Biosciences
    Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.
    Related CONTENT
    • FDA OKs GE Healthcare's AI-Powered Chest X-ray
    • OS-SiA, a Next-Gen AI-Enabled Digital Scanner, is Launched by OptraSCAN
    • Level Ex Receives Prestigious Grant
    • AI Tool Identifies Cancer Outcomes Using Radiology Reports
    • Medtronic Partners with Viz.ai to Accelerate Adoption of AI in Stroke Centers
    Business Wire09.12.19
    Paragon Biosciences LLC has launched its seventh portfolio company, Qlarity Imaging LLC, which was founded to harness the value of artificial intelligence (AI) to improve medical outcomes.
     
    Qlarity Imaging will further develop QuantX, the first-ever U.S. Food and Drug Administration (FDA)-cleared computer-aided breast cancer diagnosis system in radiology. Qlarity plans to expand the diagnostic applications of its AI technology to additional image modalities and medical conditions, with the goal of improving patient care while lowering costs for hospitals and payers.
     
    Qlarity Imaging acquired QuantX, the medical imaging AI system with intuitive displays, advanced analytics, and machine learning, initially developed at the University of Chicago based on research led by Dr. Maryellen L. Giger, and incubated at Quantitative Insights, a startup that had been launched with the support of the University of Chicago’s Polsky Center for Entrepreneurship and Innovation. A clinical study demonstrated the effectiveness of QuantX at helping radiologists interpret cancerous and non-cancerous breast lesions, leading to a 39 percent reduction in missed breast cancers without a reduction in specificity, as well as a 20 percent overall diagnostic improvement. The study led to the FDA clearance of the AI technology for breast cancer.
     
    “By driving innovation across life sciences, Paragon fulfills its mission of improving outcomes for patients with severe medical conditions. So, we’re pleased to help further develop the first FDA-cleared, artificial intelligence-enabled diagnostic software for breast cancer MRIs,” said Paragon Biosciences Chairman and CEO Jeff Aronin. “We are entering an exciting time where advances in supercomputing and machine learning make it possible for artificial intelligence to deliver on its promise for drug discovery, drug development, and diagnostics.”
     
    Paragon’s capabilities and investment in Qlarity Imaging provide the company with the working capital needed to further develop and implement its computer-aided diagnosis system and explore expanded uses of AI-enabled diagnostic tools. Paragon Biosciences advises its portfolio companies on how to leverage AI technology to enhance the diagnostic insight of medical devices, accelerate the pace of drug development, and increase the efficacy of novel therapies.
     
    Qlarity’s AI-enabled image processing and diagnostic algorithms are based on decades of research by professor of Radiology Dr. Maryellen Giger, a pioneer in the field of computer-aided diagnosis. Now an advisor to Qlarity Imaging, Dr. Giger has conducted over 30 years of research in computer-aided diagnosis, including computer vision and machine learning for breast cancer, lung cancer, prostate cancer, lupus, and bone diseases.
     
    “When we looked at how to best commercialize and scale QuantX, the computer-aided diagnostic system originally developed at the University of Chicago, Paragon Biosciences was the perfect partner,” Dr. Giger said. “Paragon is already delivering on its promise, helping Qlarity Imaging to expand its management team, pursue new product opportunities, extend its customer base, and seek additional venture financing.”
     
    With the announcement, Qlarity Imaging becomes the third portfolio company launched by Paragon Biosciences in less than a year and the seventh launched since 2017. Over the last 19 months, Paragon Biosciences and its financial partners have invested and committed over $500 million to help Paragon’s portfolio companies develop innovative therapies and diagnostic tools.
     
    Paragon Biosciences anticipates innovating, investing in, and launching additional portfolio companies this year and next.
     
    Paragon is a life science innovator that invests in, builds, and advises bioscience companies. Its mission is to serve patients living with severe medical conditions which do not yet have adequate treatments. Paragon’s portfolio of independently run bioscience companies focus on: biopharmaceuticals, AI-enabled life science products, and advanced treatments such as cell and gene therapies. We help people live longer, healthier lives.
     
    Qlarity Imaging improves patient care by building AI-driven products that provide clinical insights radiologists do not have access to today. One of Qlarity’s initial products, QuantX Advanced, is the first FDA-cleared, computer-aided diagnosis software for radiology. QuantX integrates images from multiple modalities to assist radiologists in the assessment and characterization of breast abnormalities.

     
    Related Searches
    • lung cancer
    • medical imaging
    • development
    • ceo
    Suggested For You
    FDA OKs GE Healthcare FDA OKs GE Healthcare's AI-Powered Chest X-ray
    OS-SiA, a Next-Gen AI-Enabled Digital Scanner, is Launched by OptraSCAN OS-SiA, a Next-Gen AI-Enabled Digital Scanner, is Launched by OptraSCAN
    Level Ex Receives Prestigious Grant Level Ex Receives Prestigious Grant
    AI Tool Identifies Cancer Outcomes Using Radiology Reports AI Tool Identifies Cancer Outcomes Using Radiology Reports
    Medtronic Partners with Viz.ai to Accelerate Adoption of AI in Stroke Centers Medtronic Partners with Viz.ai to Accelerate Adoption of AI in Stroke Centers
    Medica 2019—Sports Medicine Conference Preview Medica 2019—Sports Medicine Conference Preview
    PATH Develops Ethical Guidelines on the Use of AI in Healthcare PATH Develops Ethical Guidelines on the Use of AI in Healthcare
    Integra & Tissue Analytics Partner to Advance Wound Care Trial Data Analytics Integra & Tissue Analytics Partner to Advance Wound Care Trial Data Analytics
    Third FDA Clearance for Zebra-Med Third FDA Clearance for Zebra-Med's AI Solution for Brain Bleeds Alerts
    FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial
    FDA OKs Neonatal Indication for Masimo FDA OKs Neonatal Indication for Masimo's O3 Regional Oximetry
    FDA OKs ControlRad FDA OKs ControlRad's Radiation Reduction Technology that Integrates into Mobile C-arms
    FDA Clears Masimo FDA Clears Masimo's Radius PPG, the First Tetherless SET Pulse Oximetry Sensor Solution
    FDA OKs World FDA OKs World's First AI Solution for Flagging Pulmonary Embolism
    World World's First AI Chest X-Ray Triage Product Wins FDA Nod

    Related Breaking News

    • MedAcuity, Fathom Partner on Human Factors Engineering Services

      MedAcuity, Fathom Partner on Human Factors Engineering Services

      Focused on facilitating safe and effective use of medical devices, HFE is a critical aspect of product development.
      Michael Barbella 01.25.21

    • Cretex Companies CEO Steps Down

      Cretex Companies CEO Steps Down

      Jeff Wollerman will succeed Lynn Schuler as CEO of the company.
      Charles Sternberg, Assistant Editor 01.22.21

    • Data Show Porex

      Data Show Porex's Medical Device Filtration Materials Protect Against Virus, Bacteria Spread

      Company initiates VFE testing for its porous polymer-based materials; results show components protect against certain aerosolized viruses.
      Michael Barbella 01.22.21


    • Endoscopic Hemostasis Devices Market Valued at $730 Million

      Endoscopic Hemostasis Devices Market Valued at $730 Million

      Value has driven by the recent approval of new devices.
      Michael Barbella 01.22.21

    • Henry Schein Buys Majority Interest in Prism Medical Products

      Henry Schein Buys Majority Interest in Prism Medical Products

      PRISM will operate as a subsidiary of Henry Schein Medical and will be managed separately as an individual division.
      Michael Barbella 01.22.21

    • Neurological
      Boston Scientific

      Boston Scientific's Vercise Genus DBS Earns FDA Approval

      Fourth-generation DBS portfolio features full-body MR conditional devices.
      Sam Brusco, Associate Editor 01.22.21


    • Biotech Team Develops ELISA Protocol for COVID-19 Antibody Detection

      Biotech Team Develops ELISA Protocol for COVID-19 Antibody Detection

      The new detection method can help determine whether patients have had COVID-19 and if they might still have immunity to the disease.
      Michael Barbella 01.22.21

    • TPI Partners with Zeiss

      TPI Partners with Zeiss

      Enables TPI to deliver 3D X-Ray Measurement capabilities for Quality Assurance for its clients.
      Charles Sternberg, Assistant Editor 01.21.21

    • Tubing & Extrusion
      PPE Moves into New Manufacturing Facility

      PPE Moves into New Manufacturing Facility

      New building is twice the size of the old one.
      Charles Sternberg, Assistant Editor 01.21.21


    • Neurent Medical Closes $25 Million Series B Financing

      Neurent Medical Closes $25 Million Series B Financing

      Supports the expansion of the company’s clinical and commercial operations.
      Charles Sternberg, Assistant Editor 01.21.21

    • Alcon Releases PRECISION1 for Astigmatism Contact Lenses in U.S.

      Alcon Releases PRECISION1 for Astigmatism Contact Lenses in U.S.

      The daily disposable, silicone hydrogel contact lens for astigmatism will roll out concurrently worldwide beginning in February.
      Sam Brusco, Associate Editor 01.21.21

    • Diagnostics
      FDA OKs Canon Medical

      FDA OKs Canon Medical's AI-Powered, 90cm Bore CT

      Company claims the Aquilion Exceed LB CT offers the industry's largest bore opening.
      Sam Brusco, Associate Editor 01.21.21


    • Molding
      Freudenberg Medical Expands Injection Molding Operations

      Freudenberg Medical Expands Injection Molding Operations

      Adds new machines at its Baldwin Park, California facility.
      Freudenberg Medical 01.21.21

    • Plitek Adds New Slitting Capacity

      Plitek Adds New Slitting Capacity

      Expands its vertically integrated capabilities.
      Plitek 01.21.21

    • FDA Grants Emergency Use Authorization for COVID-19 Rapid Antibody Fingerstick Test

      FDA Grants Emergency Use Authorization for COVID-19 Rapid Antibody Fingerstick Test

      The serology test can be used in point-of-care settings, delivering results in 15-20 minutes.
      Business Wire 01.21.21


    Trending
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Cytotron Gains Breakthrough Status To Treat Breast, Liver, And Pancreatic Cancers
    • Hardy Diagnostics Releases Rapid Test For COVID-19
    • Masimo Earns CE Mark For New Fingertip Pulse Oximeter
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    Breaking News
    • MedAcuity, Fathom Partner on Human Factors Engineering Services
    • Cretex Companies CEO Steps Down
    • Data Show Porex's Medical Device Filtration Materials Protect Against Virus, Bacteria Spread
    • Endoscopic Hemostasis Devices Market Valued at $730 Million
    • Henry Schein Buys Majority Interest in Prism Medical Products
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    NIH Study Compares Low-Fat, Plant-based to Low-Carb, Animal-Based Diet
    Gadot Positions Mineral Line for Vegan Market
    Nutritfy India to Launch Global Broadcast Channel Covering Nutrition
    Coatings World

    Latest Breaking News From Coatings World

    APV Engineered Coatings Reflects on 2020
    LINE-X Launches Dealer Program with International Truck
    Mankiewicz Announces Leadership Change in Aviation Division
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MedAcuity, Fathom Partner on Human Factors Engineering Services
    Cretex Companies CEO Steps Down
    Data Show Porex's Medical Device Filtration Materials Protect Against Virus, Bacteria Spread
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pfizer, BioNTech Enter Vax Pact with COVAX
    FDA Approves Janssen’s CABENUVA
    AGC Biologics Appoints Boulder Site GM
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Weekly Recap: JLo Beauty Launches, Unilever Partners with Alibaba, Estée Lauder Appoints SVP & More
    Coty Appoints Chief Procurement Officer
    Lageen Tubes Launches Mono-Material PE Tube Solutions
    Happi

    Latest Breaking News From Happi

    SV Labs Acquired by PE
    Moroccan Gold Series Launches NuDo Shampoo
    Youbody Debuts Waterless Body Wash
    Ink World

    Latest Breaking News From Ink World

    BOBST Demonstrates Future of Flexible Packaging Production at Virtual Open House
    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    AR Packaging Acquiring Firstan Holdings Ltd
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Gallus planning virtual event for March
    Lemu Group engineers mask-making machine
    Niagara Label upgrades with Nilpeter flexo press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Freudenberg to Establish Apparel Interlining Competence Centers
    Minet Adds Spunlace Line in Romania
    Lemu Group Engineers Mask-Making Machine
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    First Patient Implanted With NEXXT MATRIXX SA Cervical Turn-Lock System
    Cretex Companies CEO Steps Down
    Conformis Enters Development & Supply Agreement with SITES Medical
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Ambiq Wins IoT Semiconductor Company of the Year Award
    Ynvisible Names Michael Robinson CEO, Jani-Mikael Kuusisto SVP Ventures

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login